Providing PEP/PrEP in the Pharmacy Setting: Illinois Edition

Target Audience

The educational design of this activity addresses the needs of clinical and community pharmacists involved in the care of patients at risk for HIV.

Program Overview

This activity will focus on the specific protocols, details, and policies necessary for pharmacists practicing in Illinois to implement postexposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP). This state primer is best used as an additional resource to the monograph in this curriculum, Providing PEP/PrEP in the Pharmacy Setting: A Comprehensive User Guide 2023. The monograph addresses all the clinical and behavioral aspects of HIV prevention, whereas the state primer will provide specific requirements from the state Board of Pharmacy.

Educational Objectives 

After completing this activity, the participant should be better able to:

• Describe the state-specific legislative decisions that allow for pharmacist-led or pharmacy-based direct delivery of PEP and PrEP services
• Discuss state-specific process and boards of pharmacy protocols for PEP/PrEP laboratory testing and prescribing, monitoring, and referral, as required

Pharmacist Accreditation Statement

 Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing   pharmacy education with Commendation.

Credit Designation

Global Education Group designates this continuing education activity for 0.25 contact hours (0.025 CEUs) of the Accreditation Council for Pharmacy Education (Universal Activity Number 0530-9999-23-004-H02-P).

This is a knowledge-based activity.

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must score 100% on the posttest and complete the program evaluation. Pharmacists must check the CPE Monitor for credits within 60 days of the activity. Credit for pharmacists cannot be issued after 60 days.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosures of Relevant Financial Relationships

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.  

All relevant financial relationships have been mitigated. 

The faculty have the following relevant financial relationships with ineligible companies:

Michael Wasz: Nothing to disclose

The planners and managers at Global Education Group and Integritas Communications have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Global Education Group and Integritas Communications do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

System Requirements

PC

1.4 GHz Intel Pentium 4 or faster processor (or equivalent)

Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)

512 MB of RAM (1 GB recommended)
Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome
For HTML Client – Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above) 

MAC 

1.83 GHz Intel Core Duo or faster processor

512 MB of RAM (1 GB recommended)

MAC OS X 10.12, 10.13, and 10.14
Mozilla Firefox, Apple Safari, Google Chrome
For HTML Client – Google Chrome (v70.0 & above),
Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above)